Linessa 21 0.125 mg (Desogestrel TABLET) 0.125 MG

Linessa 21 0.125 mg is a hormonal contraceptive tablet containing desogestrel. It is used for birth control and may also help regulate menstrual cycles. This oral contraceptive is designed for daily use.

Strength

0.125 MG

Pack Size

Manufacturer / TM Owner

ASPEN PHARMACARE CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Linessa 21 0.125 mg is primarily used for birth control. It works by preventing ovulation and thickening cervical mucus to block sperm. Some users may also take it to manage menstrual irregularities. Desogestrel, the active ingredient, is a progestin that helps regulate hormonal levels.

Side Effects

Common effects of Linessa 21 0.125 mg may include changes in menstrual bleeding patterns, such as lighter or more frequent periods. Some users may experience headaches, breast tenderness, or nausea. These effects vary and are not experienced by everyone.

Precautions & Warnings

Linessa 21 0.125 mg should be used as directed by a healthcare provider. It is important to take the tablet at the same time each day for maximum effectiveness. Users should be aware of potential side effects and consult a healthcare provider if any concerns arise.

Avoid Interactions

Linessa 21 0.125 mg may interact with certain medications, including some antibiotics and anticonvulsants. It is advisable to discuss all current medications with a healthcare provider. Alcohol and other substances may also affect the efficacy of the contraceptive.

Frequently Asked Questions

Linessa 21 0.125 mg is primarily used for birth control and may also help regulate menstrual cycles.

Linessa 21 0.125 mg should be taken orally, at the same time each day, as directed by a healthcare provider.

Common side effects may include changes in menstrual bleeding, headaches, breast tenderness, and nausea.

Yes, Linessa 21 0.125 mg may interact with certain antibiotics and anticonvulsants. Always consult a healthcare provider.

Effectiveness varies; it may take some time for the contraceptive to reach full effectiveness. Follow healthcare provider guidance.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.